August 24, 2026

Amgen Inc. (AMGN) Investor Outlook: Exploring the Balance of Growth and Dividend Appeal

Amgen Inc. (NASDAQ: AMGN), a stalwart in the healthcare sector, continues to capture the attention of investors with its robust portfolio of therapeutics and a significant..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential Amidst a 6.13% Dividend Yield

Pfizer, Inc. (NYSE: PFE) stands as a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a robust market capitalization of $159.99..

Insmed Incorporated (INSM): Analyst Consensus Projects 59% Upside—A Biotech Powerhouse with Robust Growth Potential

Investors with an appetite for biotechnology stocks may find Insmed Incorporated (NASDAQ: INSM) an intriguing prospect. With a current market capitalization of $27.47 billion, Insmed is..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring Growth Potential with a Robust Pipeline and Strategic Alliances

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a formidable player in the biotechnology sector, captivating investor interest with its innovative therapeutic developments and strategic collaborations. With..

ResMed Inc. (RMD) Stock Analysis: Navigating a 6.04% Potential Upside Amidst Growth and Stability

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, is making waves with its innovative digital health and cloud-connected medical devices. With a market..

Edwards Lifesciences (EW) Stock Analysis: A 12.44% Upside Sparks Investor Interest

Edwards Lifesciences Corporation (NYSE: EW), a leading name in the medical devices sector specializing in cardiovascular disease treatment, presents a compelling case for investors seeking growth..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Promising 15.63% Upside in Innovative Cancer Treatments

For investors seeking opportunities in the biotechnology sector, BeOne Medicines Ltd. (ONC) presents an intriguing proposition. Based in Basel, Switzerland, this oncology-focused biotech company has carved..

Sanofi (SNY) Investor Outlook: A 17% Upside in the Healthcare Giant’s Future?

Sanofi (NASDAQ: SNY), a leading name in the healthcare sector, continues to pique the interest of investors with its robust market presence and a promising potential..

Labcorp Holdings Inc. (LH) Stock Analysis: Navigating a 0.42% Upside with Robust Revenue Growth

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable force in the healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of..

GSK plc (GSK) Stock Report: Exploring a Healthcare Giant with a 10.81% Potential Upside

GSK plc (NYSE: GSK), a cornerstone in the healthcare sector, offers investors a promising opportunity with a potential upside of 10.81%, according to analyst projections. With..

DexCom, Inc. (DXCM) Investor Outlook: Navigating the Healthcare Sector with Promising Growth Potential

DexCom, Inc. (NASDAQ: DXCM) stands as a leading innovator in the healthcare sector, particularly within the medical devices industry. Specializing in continuous glucose monitoring (CGM) systems,..

Humana Inc. (HUM) Stock Analysis: Evaluating Growth Potential with a 9.91% Upside

Humana Inc. (NYSE: HUM), a prominent player in the healthcare sector, has captured the attention of investors with its robust performance and strategic positioning within the..

CVS Health Corporation (CVS) Stock Analysis: 24.79% Potential Upside Piques Investor Interest

Investors in CVS Health Corporation (NYSE: CVS) are eyeing a substantial potential upside of 24.79%, as indicated by the average target price of $116.08 set by..

Insulet Corporation (PODD) Stock Analysis: Unpacking a Strong 16% Upside Potential

Insulet Corporation (NASDAQ: PODD), a prominent player in the medical devices industry, specializes in insulin delivery systems, gaining substantial attention from investors with its innovative Omnipod..

Gilead Sciences, Inc. (GILD) Stock Analysis: Unpacking the Upside Potential Amidst a 7.72% Forecasted Growth

Gilead Sciences, Inc. (NASDAQ: GILD) has long been a pivotal player in the healthcare sector, specifically within the general drug manufacturing industry. With a market capitalization..

Boston Scientific Corporation (BSX) Stock Analysis: Unveiling the 24.46% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, specifically within the medical devices industry, is catching the eye of investors with a..

Merck & Company, Inc. (MRK) Stock Analysis: Navigating a Potential -3.13% Downside Despite Robust Buy Ratings

Merck & Company, Inc. (MRK), a stalwart in the healthcare sector, continues to stand out among drug manufacturers with a commanding market capitalization of $376.37 billion...

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 29% Potential Upside Amidst Market Volatility

Zoetis Inc. (NYSE: ZTS), a leader in the animal health industry, presents an intriguing investment opportunity for those willing to navigate its current market fluctuations. With..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating Its 6.53% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is making waves in the healthcare sector, particularly the medical devices industry. With a market capitalization of $19.26 billion, the..

Waters Corporation (WAT) Stock Analysis: Revenue Growth Soars Over 113% Amid Strategic Expansion

Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, presents an intriguing opportunity for investors seeking exposure..

Search

Funds

August 24, 2026

Search

Funds

August 24, 2026

FTSE 100

Funds